XerpaAI bags $6 million in seed funding for expanding AI development and growth
XerpaAI Secures $6 Million in Seed Funding
XerpaAI, an AI growth platform, has secured $6 million in seed funding, aiming to revolutionize the growth lifecycle for clients in blockchain, AI, and other emerging tech sectors. The funding round was led by UFLY Capital and b2venture.
Sean Son, Co-founder and CEO of XerpaAI, stated that the company was founded to address the problem of costly, inefficient, and unsustainable growth. Son compared XerpaAI to AppLovin, stating that just as AppLovin was the Sherpa for the mobile internet wave, XerpaAI will be the Sherpa for the AI-native generation.
The new capital will be used to enhance product capabilities and expand XerpaAI's global presence. The funding will also fuel product innovation, international expansion, and strategic hiring across XerpaAI's operations in Silicon Valley, Tokyo, and Singapore.
XerpaAI maintains a close operational relationship with UXLINK, a decentralized social infrastructure platform. The platform features an AI Growth Agent (AGA) system that generates compelling content, distributes it through a network of influencers, and gathers real-time market feedback.
According to Son, XerpaAI has reimagined the growth lifecycle into a scalable, intelligent engine using AI and social graph-based strategies. The company anticipates reaching profitability soon and plans future financing rounds.
The funding was also supported by various strategic investors, including key figures from the tech and venture capital industries. With this new funding, XerpaAI is well-positioned to become a major player in the AI growth market.
As XerpaAI aims to play a similar role for the AI era as AppLovin did for mobile apps, it is expected that the company will continue to disrupt the growth landscape and help businesses navigate the complexities of the AI-driven economy.
Read also:
- Nightly sweat episodes linked to GERD: Crucial insights explained
- Antitussives: List of Examples, Functions, Adverse Reactions, and Additional Details
- Asthma Diagnosis: Exploring FeNO Tests and Related Treatments
- Unfortunate Financial Disarray for a Family from California After an Expensive Emergency Room Visit with Their Burned Infant